J&J releases 2-year icotrokinra data for hard-to-treat plaque psoriasis
Go back to J&J releases 2-year icotrokinra data for hard-to-treat plaque psoriasis| Johnson & Johnson (NYSE: JNJ) | Delayed: 256.46 -2.9 (1.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $259.36 | 52 Week High | $126.07 | |||
| Open | $257.50 | 52 Week Low | $94.28 | |||
| Day High | $257.75 | P/E | 53.32 | |||
| Day Low | $254.56 | EPS | $4.81 | |||
| Volume | 2,647,164 | |||||



